Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, ...
Ligand Pharmaceuticals (LGND) continues to deliver strong returns, with shares up approximately 74% since my last 'Buy' ...
Investor's Business Daily on MSN
Stock Market Today: Dow Jones Climbs Off Lows; Nvidia Gains But Amazon Makes This Move (Live Coverage)
The Nasdaq composite reversed higher for a gain of 0.3% after an intraday drop of 1.9%. It outpaced the other indexes and ...
Detailed price information for Crinetics Pharmaceuticals Inc (CRNX-Q) from The Globe and Mail including charting and trades.
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
Royalties for the third quarter of 2025 were $46.6 million, compared with $31.7 million for the same period in 2024, with the 47% increase primarily attributable to royalties earned on Travere ...
Megaport Limited , the world's leading Network-as-a-Service (NaaS) provider, today announced it has entered into an agreement to acquire Latitude.sh, a leading global Compute-as-a-Service company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results